The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Kelch-type beta propeller
".
FunFam 6: Kelch-like family member 20
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 8 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Ubiquitin-protein transferase activity GO:0004842
Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Interferon-gamma binding GO:0019964
Interacting selectively and non-covalently with interferon-gamma. Interferon gamma is the only member of the type II interferon found so far.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Ubiquitin-protein transferase activity GO:0004842
Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
41 |
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
Q9Y2M5 (/IPI)
(31 more) |
Interferon-gamma binding GO:0019964
Interacting selectively and non-covalently with interferon-gamma. Interferon gamma is the only member of the type II interferon found so far.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
4 | Q9VUU5 (/IDA) Q9VUU5 (/IDA) Q9VUU5 (/IDA) Q9VUU5 (/IDA) |
Ubiquitin-protein transferase activity GO:0004842
Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Interferon-gamma binding GO:0019964
Interacting selectively and non-covalently with interferon-gamma. Interferon gamma is the only member of the type II interferon found so far.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
There are 21 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Golgi to endosome transport GO:0006895
The directed movement of substances from the Golgi to early sorting endosomes. Clathrin vesicles transport substances from the trans-Golgi to endosomes.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Protein K33-linked ubiquitination GO:1990390
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is added to a protein.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Golgi to endosome transport GO:0006895
The directed movement of substances from the Golgi to early sorting endosomes. Clathrin vesicles transport substances from the trans-Golgi to endosomes.
|
41 |
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
(31 more) |
Cytoskeleton organization GO:0007010
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.
|
41 |
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
(31 more) |
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Response to interferon-alpha GO:0035455
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon.
|
41 |
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
(31 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
41 |
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
Q9Y2M5 (/IMP)
(31 more) |
Proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
|
41 |
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
(31 more) |
Protein K33-linked ubiquitination GO:1990390
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is added to a protein.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Negative regulation of synaptic growth at neuromuscular junction GO:0045886
Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
25 |
B0WWP2 (/ISS)
B0WWP2 (/ISS)
B3M9V8 (/ISS)
B3NDN0 (/ISS)
B3NDN0 (/ISS)
B4GRJ2 (/ISS)
B4HIK1 (/ISS)
B4HIK1 (/ISS)
B4HIK1 (/ISS)
B4HIK1 (/ISS)
(15 more) |
Negative regulation of synaptic growth at neuromuscular junction GO:0045886
Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
4 | Q9VUU5 (/IMP) Q9VUU5 (/IMP) Q9VUU5 (/IMP) Q9VUU5 (/IMP) |
Protein autoubiquitination GO:0051865
The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink.
|
4 | Q9VUU5 (/IDA) Q9VUU5 (/IDA) Q9VUU5 (/IDA) Q9VUU5 (/IDA) |
Golgi to endosome transport GO:0006895
The directed movement of substances from the Golgi to early sorting endosomes. Clathrin vesicles transport substances from the trans-Golgi to endosomes.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Protein K33-linked ubiquitination GO:1990390
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is added to a protein.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
There are 18 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Cul3-RING ubiquitin ligase complex GO:0031463
A ubiquitin ligase complex in which a cullin from the Cul3 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a BTB-domain-containing protein.
|
88 |
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
D3Z8N4 (/ISS)
(78 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
82 |
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
(72 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
82 |
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
A0A024R940 (/IDA)
(72 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
41 |
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
(31 more) |
Actin cytoskeleton GO:0015629
The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes.
|
41 |
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
Q9Y2M5 (/TAS)
(31 more) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Cul3-RING ubiquitin ligase complex GO:0031463
A ubiquitin ligase complex in which a cullin from the Cul3 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a BTB-domain-containing protein.
|
41 |
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
Q9Y2M5 (/IDA)
(31 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
PML body GO:0016605
A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |
Cul3-RING ubiquitin ligase complex GO:0031463
A ubiquitin ligase complex in which a cullin from the Cul3 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a BTB-domain-containing protein.
|
2 | Q8VCK5 (/ISO) Q8VCK5 (/ISO) |